These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9454657

  • 1. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
    Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M.
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [Abstract] [Full Text] [Related]

  • 5. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A, Piscittelli V, Cassese F, Balbi GC, Balbi C, Cardone A.
    Minerva Ginecol; 1999 Dec; 51(7-8):261-4. PubMed ID: 10536419
    [Abstract] [Full Text] [Related]

  • 6. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Marker rhythmometry with macrophage-colony stimulating factor (M-CSF).
    Elg S, Halberg E, Ramakrishnan S, Cornélissen G, Haus E, Nicolau G, Carson L, Twiggs L, Long HJ, Halberg F.
    Chronobiologia; 1991 May 01; 18(4):141-52. PubMed ID: 1687728
    [Abstract] [Full Text] [Related]

  • 9. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul 01; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 10. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep 01; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P, Thirapagawong C, Senapad S, Suphanit I.
    Anticancer Res; 2000 Sep 01; 20(2B):1291-5. PubMed ID: 10810437
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C, Li JD, Huang H, Feng YL, Wang LH, Chen L.
    Ai Zheng; 2008 Jan 01; 27(1):92-5. PubMed ID: 18184473
    [Abstract] [Full Text] [Related]

  • 13. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM.
    Mod Pathol; 2005 Feb 01; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [Abstract] [Full Text] [Related]

  • 14. Tumor chemoconversion following surgery, chemotherapy, and normalization of serum tumor markers in a woman with a mixed type germ cell ovarian tumor.
    David YB, Weiss A, Shechtman L, Shalev E.
    Gynecol Oncol; 2002 Mar 01; 84(3):464-7. PubMed ID: 11855890
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun 01; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 16. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M, Arsenijević S, Lukić G, Arsenijević N, Ristić P, Pavlović S, Popović S, Baskić D.
    J BUON; 2007 Jun 01; 12(1):99-104. PubMed ID: 17436409
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.
    Le Meur Y, Leprivey-Lorgeot V, Mons S, José M, Dantal J, Lemauff B, Aldigier JC, Leroux-Robert C, Praloran V.
    Nephrol Dial Transplant; 2004 Jul 01; 19(7):1862-5. PubMed ID: 15150350
    [Abstract] [Full Text] [Related]

  • 18. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 01; 14(2):306-18. PubMed ID: 15734951
    [Abstract] [Full Text] [Related]

  • 19. [Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease].
    Kong QL, Zhang JM, Zhang ZX, Ge PJ, Xu YJ, Mi RS, Zhao YH, Sui YP, He W.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun 01; 24(3):298-301. PubMed ID: 12905639
    [Abstract] [Full Text] [Related]

  • 20. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
    Li L, Wang LM, Zhang W, Zhang JQ, Song HL, Yao DS, Tang Y, Chen XQ, Yang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 01; 38(2):72-6. PubMed ID: 12783691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.